US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class I · High risk Ongoing

Vy&Tea

Reason Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine.

Qikmoov LLC D-0749-2021
Class II · Moderate risk Terminated

QiYu Hand Sanitizer

Reason Subpotent

Native Promotions, INC D-0793-2021
Class II · Moderate risk Completed

Compounded Lyophilized AOD-9604

Reason Lack of Assurance of Sterility

Innoveix Pharmaceuticals Inc D-0693-2021
Class II · Moderate risk Terminated

Sulfamethoxazole and Trimethoprim Tablets

Reason Presence of Foreign Substance- Potential of metal contamination.

Aurobindo Pharma USA Inc. NDC 65862-420-05 D-0719-2021
Class III · Low risk Terminated

Acetaminophen EXTRA STRENGTH Pain Reliever / Fever Reducer

Reason Labeling: Not Elsewhere Classified The primary label contains the words "enteric coated" but the tablet is not enteric coated and should only say 'coated tablet'

LNK International, Inc. NDC 46122-649-71 D-0665-2021
Class I · High risk Terminated

Atovaquone Oral Suspension

Reason Temperature abuse: the firm received customer complaints of unusual grittiness in the product.

KVK-Tech, Inc. NDC 10702-223-21 D-0772-2021
Class II · Moderate risk Terminated

NIFEdipine EXTENDED-RELEASE TABLETS

Reason Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.

The Harvard Drug Group NDC 0904-7080-61 D-0652-2021